Fortical Nasal and Hypocalcemia
Result of checking the interaction of drug Fortical Nasal and disease Hypocalcemia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Calcitonin inhibits bone resorption, which results in decreased serum calcium levels. Following single IV doses, a marked transient inhibition of the ongoing bone resorptive process occurs, while continuous use leads to a persistent, smaller decrease in rate of bone resorption. Because of the drug's acute hypocalcemic effects, patients administered calcitonin may, theoretically, experience tetany under certain circumstances. Calcitonin should be administered cautiously to patients with preexisting hypocalcemia, since they may be particularly sensitive to these effects. Hypocalcemia should preferably be corrected prior to initiation of therapy. If calcitonin is used to increase bone mineral density, such as in osteoporosis, an adequate intake of calcium and vitamin D should be ensured throughout the course of treatment.
- "Product Information. Calcimar (calcitonin)." Rhone-Poulenc Rorer, Collegeville, PA.
- "Product Information. Miacalcin Injection, Synthetic (calcitonin)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: calcitonin
Brand Name: Fortical, Miacalcin Nasal, Miacalcin
Synonyms: Fortical Nasal Spray, Fortical